SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-236770
Filing Date
2024-10-11
Accepted
2024-10-11 16:39:01
Documents
13
Period of Report
2024-10-11
Items
Item 2.05: Cost Associated with Exit or Disposal Activities

Document Format Files

Seq Description Document Type Size
1 8-K d840872d8k.htm   iXBRL 8-K 28341
  Complete submission text file 0001193125-24-236770.txt   151723

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mtem-20241011.xsd EX-101.SCH 2843
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mtem-20241011_lab.xml EX-101.LAB 17996
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mtem-20241011_pre.xml EX-101.PRE 11257
16 EXTRACTED XBRL INSTANCE DOCUMENT d840872d8k_htm.xml XML 3674
Mailing Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729
Business Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729 512 896 1555
Molecular Templates, Inc. (Filer) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32979 | Film No.: 241367970
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)